The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
The U.S. Meals and Drug Administration (FDA) has granted uncommon pediatric drug designation for iopofosine-131 in inoperable relapsed or refractory pediatric high-grade...
Amongst sufferers with untreated, superior HER2-mutated non-small cell lung most cancers (NSCLC), remedy with Hernexeos (zongertinib) was related to a big and...
Dr. Francesca Palandri, affiliate professor of Hematology on the College of Bologna in Italy and a doctor on the IRCCS Azienda Ospedaliero-Universitaria...
